TrialJournal of experimental & clinical cancer research : CR2017

Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.

Xue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.